The Board of Directors of Johnson & Johnson has named William C. Weldon Chairman and Chief Executive Officer, and James T. Lenehan President in addition to his responsibilities as Vice Chairman, effective April 25, 2002, the date of the annual shareowners meeting. Together, they will form the Office of the Chairman. They succeed Chairman and Chief Executive Officer, Ralph S. Larsen, and Robert N. Wilson, Senior Vice Chairman of the Board and Vice Chairman of the Executive Committee.

Weldon and Lenehan currently serve as Vice Chairmen of the Board. Weldon leads the Pharmaceuticals Group as well as the Consumer Pharmaceuticals & Nutritionals Group. Lenehan has responsibility for the Medical Devices & Diagnostics Group and the Consumer & Personal Care Group.

Weldon will become the sixth Chairman in the 116-year history of Johnson & Johnson. He joined the Company in 1971 as a sales representative at McNeil Pharmaceutical. After a variety of management positions in both sales and product management, he assumed an international business development assignment for the Southeast Asia region and was stationed in the Philippines. In 1984, he became executive vice president and managing director of McNeil Limited in Korea and, in 1986, managing director of Ortho-Cilag Pharmaceutical Limited in the United Kingdom.

He returned to the United States in 1989 as vice president, sales and marketing for Janssen Pharmaceutica. In 1992, he became president of Ethicon Endo-Surgery, beginning a six-year period during which he gained experience in medical devices, serving as Company Group Chairman and Worldwide Franchise Chairman for Ethicon Endo-Surgery from 1995 through 1998. Weldon was then promoted to Executive Committee Member and Worldwide Chairman, Pharmaceuticals Group. In February 2001, Weldon was named to the Board of Directors. He is a graduate of Quinnipiac University.

Lenehan joined Johnson & Johnson in 1976 as an assistant product director in marketing at McNeil Consumer Healthcare Company. After a series of increasing responsibilities for both consumer and professional marketing, Lenehan was named McNeil's president in 1990. In 1993, Lenehan was named Company Group Chairman and Worldwide Franchise Chairman for Consumer Pharmaceuticals and a member of the Consumer Group Operating Committee. In 1994, he was promoted to Executive Committee member and Worldwide Chairman, Consumer Pharmaceuticals & Medical Devices Group. In 1999, Lenehan was named Worldwide Chairman, Medical Devices & Diagnostics Group, and in February 2001 he was named to the Board of Directors. Lenehan earned a BA from Akron University and received an MBA from Northwestern University.

The Company also announced that Robert J. Darretta has been elected a member of the Board of Directors. Darretta will become Executive Vice President and assume additional responsibility for Information Management. He will continue as Chief Financial Officer. In addition, Michael J. Dormer, Franchise Group Chairman, will become Worldwide Chairman, Medical Devices. These appointments will also be effective on April 25.